Aarey Drugs — 360° view

Aarey Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹89 crore and net profit of ₹1.37 crore for the September 2026 quarter.

Aarey Drugs (NSE: AAREYDRUGS) closed at ₹116.03 on 20 Nov 2026. Its market capitalisation is ₹370 crore and it trades at 81.8 times earnings.

Share price
₹116.03 (20 Nov 2026)
Market cap
₹370 Cr (20 Nov 2026)
P/E
81.82 (20 Nov 2026)
Revenue
₹89 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
5.58% (FY26)
ROE
2.75% (FY26)
Book value
₹53.2 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹116.90 / ₹74.60 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AAREYDRUGS

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse industrial applications

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.